RESEARCHER PROFILE
Celia J. A. Morgan
← Back to University of Exeter
C
University of Exeter
Celia J. A. Morgan works in Neurotransmitter Receptor Influence on Behavior, Schizophrenia research and treatment, Substance Abuse Treatment and Outcomes, Neuroscience and Neuropharmacology Research, Treatment of Major Depression. Recorded institutional associations include University of Exeter.
1,749Publications
10,349Citations
55H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Ketamine use: a review
2011 · 655 citationsKeep off the grass? Cannabis, cognition and addiction
2016 · 389 citationsConsequences of chronic ketamine self‐administration upon neurocognitive function and psychological wellbeing: a 1‐year longitudinal study
2009 · 373 citationsImpact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
2010 · 304 citationsAcute and chronic effects of ketamine upon human memory: a review
2006 · 302 citationsEffects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
2008 · 299 citationsAcute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers
2003 · 277 citationsJourney through the K-hole: Phenomenological aspects of ketamine use
2008 · 246 citationsCognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later
2000 · 245 citationsDopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
2013 · 215 citationsCannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
2020 · 203 citationsCannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
2010 · 195 citationsSub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
2011 · 194 citationsCannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
2013 · 193 citationsCannabidiol enhances consolidation of explicit fear extinction in humans
2013 · 191 citationsKetamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex‐users with polydrug and non‐using controls
2008 · 187 citationsKetamine for the treatment of mental health and substance use disorders: comprehensive systematic review
2021 · 186 citationsAcute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
2014 · 183 citationsThe Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity
2014 · 178 citationsAcute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses
2016 · 178 citationsAdjunctive Ketamine With Relapse Prevention–Based Psychological Therapy in the Treatment of Alcohol Use Disorder
2022 · 174 citationsKetamine for the treatment of addiction: Evidence and potential mechanisms
2018 · 162 citationsKetamine treatment for depression: opportunities for clinical innovation and ethical foresight
2017 · 160 citationsJust say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
2014 · 140 citationsIndividual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
2018 · 140 citations
